JPWO2022045335A1 - - Google Patents

Info

Publication number
JPWO2022045335A1
JPWO2022045335A1 JP2022545757A JP2022545757A JPWO2022045335A1 JP WO2022045335 A1 JPWO2022045335 A1 JP WO2022045335A1 JP 2022545757 A JP2022545757 A JP 2022545757A JP 2022545757 A JP2022545757 A JP 2022545757A JP WO2022045335 A1 JPWO2022045335 A1 JP WO2022045335A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022545757A
Other languages
Japanese (ja)
Other versions
JP7716111B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022045335A1 publication Critical patent/JPWO2022045335A1/ja
Application granted granted Critical
Publication of JP7716111B2 publication Critical patent/JP7716111B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2022545757A 2020-08-31 2021-08-30 神経変性疾患の症状の緩和又は治療のための貼付剤 Active JP7716111B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020145562 2020-08-31
JP2020145562 2020-08-31
PCT/JP2021/031712 WO2022045335A1 (ja) 2020-08-31 2021-08-30 神経変性疾患の症状の緩和又は治療のための貼付剤

Publications (2)

Publication Number Publication Date
JPWO2022045335A1 true JPWO2022045335A1 (https=) 2022-03-03
JP7716111B2 JP7716111B2 (ja) 2025-07-31

Family

ID=80353475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022545757A Active JP7716111B2 (ja) 2020-08-31 2021-08-30 神経変性疾患の症状の緩和又は治療のための貼付剤

Country Status (8)

Country Link
US (1) US20230293510A1 (https=)
EP (1) EP4205744A4 (https=)
JP (1) JP7716111B2 (https=)
CN (1) CN115989025A (https=)
AU (1) AU2021331298A1 (https=)
CA (1) CA3193154A1 (https=)
TW (1) TW202228688A (https=)
WO (1) WO2022045335A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114848613A (zh) * 2022-05-09 2022-08-05 山东中医药大学 一种东莨菪碱可溶性微针贴片及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1160475A (ja) * 1997-06-26 1999-03-02 Verteq Inc 高可塑薬剤の経皮配給用接着剤混合物
JP2006516267A (ja) * 2003-01-17 2006-06-29 エルテーエス ローマン テラピー−ジステーメ アーゲー コリンエステラーゼ阻害剤中毒の医薬的予防方法並びにこれに適する活性物質および医薬
CN1994307A (zh) * 2006-12-12 2007-07-11 中国人民解放军第二军医大学 一种预防有机磷酸酯类化合物中毒的复方经皮给药制剂
JP2015083569A (ja) * 2008-05-30 2015-04-30 マイラン・インコーポレーテッド 安定化された経皮薬物送達システム
JP2020525546A (ja) * 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー スコポラミン及びシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070010550A1 (en) * 2005-07-08 2007-01-11 The Board Of Regents Of The University Of Texas Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia
US20080090808A1 (en) * 2006-10-17 2008-04-17 Franklin Volvovitz Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction
US20220160697A1 (en) * 2019-03-19 2022-05-26 Nobelpharma Co., Ltd. Pharmaceutical composition having excellent drug absorption into the living body and excellent chemical stability

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1160475A (ja) * 1997-06-26 1999-03-02 Verteq Inc 高可塑薬剤の経皮配給用接着剤混合物
JP2006516267A (ja) * 2003-01-17 2006-06-29 エルテーエス ローマン テラピー−ジステーメ アーゲー コリンエステラーゼ阻害剤中毒の医薬的予防方法並びにこれに適する活性物質および医薬
CN1994307A (zh) * 2006-12-12 2007-07-11 中国人民解放军第二军医大学 一种预防有机磷酸酯类化合物中毒的复方经皮给药制剂
JP2015083569A (ja) * 2008-05-30 2015-04-30 マイラン・インコーポレーテッド 安定化された経皮薬物送達システム
JP2020525546A (ja) * 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー スコポラミン及びシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MONTERO,M.A, ET AL.: "Control of drooling using transdermal scopolamine skin patches. A case report", MED ORAL PATOL ORAL CIR BUCAL, vol. 13, no. 1, JPN6021039368, 2008, pages 27 - 30, XP055904111, ISSN: 0005572138 *
MORISE,B.T. ET AL.: "Scopolamine loaded in natural rubber latex as a future transdermal patch for sialorrhea treatment", INTERNATIONAL JOURNAL OF PLOLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, vol. 68, no. 13, JPN6021039370, 2019, pages 788 - 795, XP055904116, ISSN: 0005572139, DOI: 10.1080/00914037.2018.1506984 *
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, vol. 103, no. 4, JPN6025014702, 1990, pages 615 - 618, ISSN: 0005572140 *

Also Published As

Publication number Publication date
JP7716111B2 (ja) 2025-07-31
EP4205744A4 (en) 2024-09-11
EP4205744A1 (en) 2023-07-05
AU2021331298A1 (en) 2023-03-23
CA3193154A1 (en) 2022-03-03
CN115989025A (zh) 2023-04-18
US20230293510A1 (en) 2023-09-21
WO2022045335A1 (ja) 2022-03-03
TW202228688A (zh) 2022-08-01

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
JPWO2022045335A1 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230210

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240402

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250415

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250507

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250708

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250711

R150 Certificate of patent or registration of utility model

Ref document number: 7716111

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150